← All trials
NCT01661933
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- Mar 1, 2014
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of QueenslandLead sponsor
- University of QueenslandStudy director
- National Health and Medical Research Council, AustraliaCollaborator
- University of QueenslandReponsible party - principal investigator
- James Cook University Hospital, Middlesbrough, UKOverall official - principal investigator
- Logan UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.